These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 9711401)

  • 21. Therapeutic use of colony stimulating factors for established neutropenic fever.
    Walton SM
    W V Med J; 1998; 94(1):26-8. PubMed ID: 9505567
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytokines in tumor therapy (GM-CSF, G-CSF, and IL-3). Proceedings of the satellite symposium to the 15th UICC Congress. Hamburg, Federal Republic of Germany, August 18, 1990.
    Am J Clin Oncol; 1991; 14 Suppl 1():S1-63. PubMed ID: 1710873
    [No Abstract]   [Full Text] [Related]  

  • 23. The myeloid colony-stimulating factors: introduction and overview.
    Peters WP
    Semin Hematol; 1991 Apr; 28(2 Suppl 2):1-5. PubMed ID: 1712123
    [No Abstract]   [Full Text] [Related]  

  • 24. Use of granulocyte-macrophage colony stimulating factor (GM-CSF) in prevention and treatment of fungal infections.
    Jones TC
    Eur J Cancer; 1999 Aug; 35 Suppl 3():S8-10. PubMed ID: 10645213
    [No Abstract]   [Full Text] [Related]  

  • 25. Clinical trials of myeloid growth factors.
    Glaspy JA; Golde DW
    Exp Hematol; 1990 Nov; 18(10):1137-41. PubMed ID: 1698650
    [No Abstract]   [Full Text] [Related]  

  • 26. The potential role of cytokine therapy for fungal infections in patients with cancer: is recovery from neutropenia all that is needed?
    Rodriguez-Adrian LJ; Grazziutti ML; Rex JH; Anaissie EJ
    Clin Infect Dis; 1998 Jun; 26(6):1270-8. PubMed ID: 9636845
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Macrophage function activating cytokines: potential clinical application.
    Nemunaitis J
    Crit Rev Oncol Hematol; 1993 Apr; 14(2):153-71. PubMed ID: 8357512
    [No Abstract]   [Full Text] [Related]  

  • 28. Use of macrophage colony-stimulating factor in the treatment of fungal infections.
    Nemunaitis J
    Clin Infect Dis; 1998 Jun; 26(6):1279-81. PubMed ID: 9636846
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recombinant hematopoietic growth factors in bone marrow transplantation.
    Nemunaitis J
    Cancer Treat Res; 1995; 76():225-48. PubMed ID: 7577337
    [No Abstract]   [Full Text] [Related]  

  • 30. Clinical applications of haemopoietic growth factors.
    Khwaja A; Linch DC
    Leuk Lymphoma; 1992; 7 Suppl():69-72. PubMed ID: 1283549
    [No Abstract]   [Full Text] [Related]  

  • 31. Pleiotropic effects of cytokines: clinical and preclinical studies.
    Bukowski RM; Olencki T; McLain D; Finke JH
    Stem Cells; 1994; 12 Suppl 1():129-40; discussion 140-1. PubMed ID: 7696957
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor: comparisons and potential for use in the treatment of infections in nonneutropenic patients.
    Root RK; Dale DC
    J Infect Dis; 1999 Mar; 179 Suppl 2():S342-52. PubMed ID: 10081506
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Update on cytokines and growth factors].
    Dorval T
    Bull Cancer; 1998 Jan; 85(1):89-90. PubMed ID: 9752358
    [No Abstract]   [Full Text] [Related]  

  • 34. Should hematopoietic growth factors routinely be given concurrently with cytotoxic chemotherapy?
    Croockewit AJ; Koopmans PP; de Pauw BE
    Clin Pharmacol Ther; 1996 Jan; 59(1):1-6. PubMed ID: 8549028
    [No Abstract]   [Full Text] [Related]  

  • 35. Monocyte-macrophages, granulocyte-macrophage colony-stimulating factor, and prolonged survival among patients with acute myeloid leukemia and stem cell transplants.
    Giles FJ
    Clin Infect Dis; 1998 Jun; 26(6):1282-9. PubMed ID: 9636847
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor: double-edged swords.
    Wilson RF; Henry TD
    J Am Coll Cardiol; 2005 Nov; 46(9):1649-50. PubMed ID: 16256863
    [No Abstract]   [Full Text] [Related]  

  • 37. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor (1).
    Lieschke GJ; Burgess AW
    N Engl J Med; 1992 Jul; 327(1):28-35. PubMed ID: 1375975
    [No Abstract]   [Full Text] [Related]  

  • 38. The 11th Bristol-Myers Squibb Nagoya International Cancer Treatment Symposium. Cytokines and New Anticancer Agents on the Horizon of Oncology. Nagoya, Japan, 24-25 November 1995.
    Cancer Chemother Pharmacol; 1996; 38 Suppl():S1-119. PubMed ID: 8777775
    [No Abstract]   [Full Text] [Related]  

  • 39. Granulocyte colony-stimulating factor: a new approach in the treatment of childhood neutropenia.
    Little FM; Pais RC; Winton E; Ragab AH
    J Med Assoc Ga; 1992 Aug; 81(8):437-41. PubMed ID: 1380973
    [No Abstract]   [Full Text] [Related]  

  • 40. Lack of benefit of granulocyte macrophage or granulocyte colony stimulating factor in patients with febrile neutropenia.
    Siddiqui T; Burney IA; Kakepoto GN; Khurshid M; Salam A; Smego RA
    J Pak Med Assoc; 2002 May; 52(5):206-10. PubMed ID: 12174492
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.